FDA Releases GDUFA III Commitment Letter By PacConAdmin | October 31, 2021 The FDA has released its commitment letter for the reauthorization of the Generic Drug User Fee Act (GDUFA), hammered out over several meetings with industry this year. Source: Drug Industry Daily Posted in Drug Industry Daily